Multicentre EORTC study 16997: Feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers
Open Access
- 31 May 2005
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 41 (8), 1150-1157
- https://doi.org/10.1016/j.ejca.2005.02.015
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Ras on the RoundaboutScience, 2005
- Phase I study of gemcitabine given weekly as a short infusion for non-small cell lung cancer: results and possible immune system-related mechanismsLung Cancer, 2004
- Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, α-interferon, cisplatin (FAP)Urologic Oncology: Seminars and Original Investigations, 2003
- Farnesyl transferase inhibitors in clinical developmentExpert Opinion on Investigational Drugs, 2003
- Farnesyl Transferase Inhibitors Enhance Death Receptor Signals and Induce Apoptosis in Multiple Myeloma CellsLeukemia & Lymphoma, 2003
- Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabineCancer, 2002
- Phase II Trial of Weekly Paclitaxel in Patients With Previously Treated Advanced Urothelial CancerJournal of Clinical Oncology, 2002
- A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinumEuropean Journal Of Cancer, 1998
- Second Line Chemotherapy with Ifosfamide as Outpatient Treatment for Advanced Bladder CancerAmerican Journal of Clinical Oncology, 1997
- Phase II Trial of Ifosfamide, Fluorouracil, and Folinic Acid (FIFO Regimen) in Relapsed and Refractory Urothelial CancerCancer Investigation, 1995